Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022

BUY
$0.61 - $0.75 $16,019 - $19,696
26,262 Added 127.65%
46,836 $34,000
Q4 2021

Jan 28, 2022

SELL
$0.66 - $1.1 $14,577 - $24,295
-22,087 Reduced 51.77%
20,574 $14,000
Q3 2021

Nov 10, 2021

SELL
$0.9 - $1.31 $3,757 - $5,469
-4,175 Reduced 8.91%
42,661 $45,000
Q2 2021

Aug 03, 2021

BUY
$0.87 - $1.58 $4,226 - $7,675
4,858 Added 11.57%
46,836 $52,000
Q1 2021

May 06, 2021

BUY
$1.31 - $2.35 $1,439 - $2,582
1,099 Added 2.69%
41,978 $64,000
Q4 2020

Feb 11, 2021

BUY
$1.26 - $2.75 $51,507 - $112,417
40,879 New
40,879 $52,000

Others Institutions Holding SNGX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About SOLIGENIX, INC.


  • Ticker SNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,105,200
  • Market Cap $125M
  • Description
  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...
More about SNGX
Track This Portfolio

Track Argi Investment Services, LLC Portfolio

Follow Argi Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argi Investment Services, LLC with notifications on news.